MTOR and nonpapillary renal cell carcinoma: To our knowledge, this is the first report that evaluates the prognostic role and interaction to immune infiltration of mTOR in ccRCC patients simultaneously, which revealed p-mTOR could be a prognostic factor and mTOR regulate multiple immune features in ccRCC patients.